PATENT CLAIM ANALYSIS

Application Number: 15756058
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "204100"]

Abstract:
The present invention relates to a composition for intracellular delivery containing an adenovirus protein VI-derived peptide and an anti-cancer pharmaceutical composition containing the same. According to the present invention, the use of the peptide or peptide-polymer composite of the present invention improves intracellular delivery efficiency of a nucleic acid, a peptide, a poly-peptide, an antibody, a chemical material, or a virus. Therefore, the peptide or peptide-polymer composite of the present invention can be favorably used as an intracellular delivery system for various therapeutics.

Claim (Index 27):
The method of  claim 18 , wherein the peptide is additionally linked to positively-charged amino acid at the N-terminus or C-terminus of the peptide of SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 88.0
- Lexical Diversity: 1.97872
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15538975', '12557031', '10353522', '15313674', '10018103']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7446684257605304
- 35 USC 102 Novelty (BERT): 0.5068118856916939
- Combined Prediction Score: 0.7208827717536467
- Mean Citation Score: 249.94336000000004
- Max Citation Score: 258.81607
- Similarity Product: 177.85903833854678

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test